Top compounds associated with response to C1orf106


Feature Type Standardized
Nominal ANOVA
mRNA austocystin d CTRPv2 pan-cancer AAC 0.2 2e-06
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 3e-06
mRNA canertinib CTRPv2 pan-cancer AAC 0.19 6e-06
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 7e-06
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA Vandetanib CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA AZD0530 CTRPv2 pan-cancer AAC 0.17 4e-05
Download CSV